Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Rexgene Biotech Co., Ltd. — REXAHN PHARMACEUTICALS, INC. insider: 2 transactions · InsiderLens

Home / Insiders / Rexgene Biotech Co., Ltd.

Rexgene Biotech Co., Ltd.

10% owner at REXAHN PHARMACEUTICALS, INC. · on record since Nov 30, 2007

Insider trading activity of Rexgene Biotech Co., Ltd.

Transactions on record: 2; since Dec 26, 2007

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Dec 26, 2007

Figures computed from official regulatory filings — methodology.

Companies where Rexgene Biotech Co., Ltd. has traded

REXAHN PHARMACEUTICALS, INC.2 tx · $1M · Dec 26, 2007

Track record of Rexgene Biotech Co., Ltd.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Rexgene Biotech Co., Ltd.

Co-insiders of Rexgene Biotech Co., Ltd.

Ahn Chang HoREXAHN PHARMACEUTICALS, INC.
Ahn InokREXAHN PHARMACEUTICALS, INC.
Ainsworth SeanREXAHN PHARMACEUTICALS, INC.
Beever CharlesREXAHN PHARMACEUTICALS, INC.
Benaim ElyREXAHN PHARMACEUTICALS, INC.
Bennett JeanREXAHN PHARMACEUTICALS, INC.
Benton SusanREXAHN PHARMACEUTICALS, INC.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Brandt Peter C.REXAHN PHARMACEUTICALS, INC.

CARTHY MARKREXAHN PHARMACEUTICALS, INC.

Cheong Kwang SooREXAHN PHARMACEUTICALS, INC.

Chung Sung-KeeREXAHN PHARMACEUTICALS, INC.

Ferraro FrankREXAHN PHARMACEUTICALS, INC.

Foundation Fighting Blindness, Inc.REXAHN PHARMACEUTICALS, INC.

Foundation Fighting Blindness Retinal Degeneration FundREXAHN PHARMACEUTICALS, INC.

Gagnon Robert E.REXAHN PHARMACEUTICALS, INC.

Gallagher CamREXAHN PHARMACEUTICALS, INC.

Graves Adrienne LREXAHN PHARMACEUTICALS, INC.

Hoffman Freddie AnnREXAHN PHARMACEUTICALS, INC.

Hoffmann BernhardREXAHN PHARMACEUTICALS, INC.

HOLADAY JOHN W DRREXAHN PHARMACEUTICALS, INC.

Hwang Si MoonREXAHN PHARMACEUTICALS, INC.

Jayagopal AshwathREXAHN PHARMACEUTICALS, INC.

Jeong Tae HeumREXAHN PHARMACEUTICALS, INC.

Jhaveri Nirav S.REXAHN PHARMACEUTICALS, INC.

Kang Y MicheleREXAHN PHARMACEUTICALS, INC.

Kivel RichardREXAHN PHARMACEUTICALS, INC.

Korean Rexahn Investors Voting TrustREXAHN PHARMACEUTICALS, INC.

Kwon Suk HyungREXAHN PHARMACEUTICALS, INC.

Magrath GeorgeREXAHN PHARMACEUTICALS, INC.

MANUSO JAMES S JREXAHN PHARMACEUTICALS, INC.

McIntosh David MREXAHN PHARMACEUTICALS, INC.

MEYER ALAN RREXAHN PHARMACEUTICALS, INC.

Nolan LisaREXAHN PHARMACEUTICALS, INC.

Park Sung SookREXAHN PHARMACEUTICALS, INC.

Park Young SoonREXAHN PHARMACEUTICALS, INC.

Patel Ronil A.REXAHN PHARMACEUTICALS, INC.

Pepose JayREXAHN PHARMACEUTICALS, INC.

Price Ben GilREXAHN PHARMACEUTICALS, INC.

Rhee Jang HanREXAHN PHARMACEUTICALS, INC.

Rodgers Richard JREXAHN PHARMACEUTICALS, INC.

SCHACHLE JOSEPH KREXAHN PHARMACEUTICALS, INC.

Soni RakeshREXAHN PHARMACEUTICALS, INC.

Sooch MinaREXAHN PHARMACEUTICALS, INC.

Steinfels George FREXAHN PHARMACEUTICALS, INC.

Sullivan LaraREXAHN PHARMACEUTICALS, INC.

Suzdak Peter DavidREXAHN PHARMACEUTICALS, INC.

Swirsky Douglas JREXAHN PHARMACEUTICALS, INC.

YERXA BENJAMIN RREXAHN PHARMACEUTICALS, INC.

Zaremba Rabourn AmyREXAHN PHARMACEUTICALS, INC.

Company	Filed	Type	Qty	Price	Value · USD	Src
REXAHN PHARMACEUTICALS, INC.	Dec 26, 2007	Award	714,286	1.40	$1M	SEC
REXAHN PHARMACEUTICALS, INC.	Dec 26, 2007	AwardD	142,857	0.00	$0	SEC